Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2003;107:1170-1175
Published online before print February 24, 2003, doi: 10.1161/01.CIR.0000051467.31874.29
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
107/8/1170    most recent
01.CIR.0000051467.31874.29v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Communal, C.
Right arrow Articles by Hajjar, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Communal, C.
Right arrow Articles by Hajjar, R. J.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Seniors' Health
Related Collections
Right arrow Other heart failure

(Circulation. 2003;107:1170.)
© 2003 American Heart Association, Inc.


Basic Science Reports

Decreased Efficiency of Adenovirus-Mediated Gene Transfer in Aging Cardiomyocytes

Catherine Communal, PhD; Fawzia Huq, MD; Djamel Lebeche, PhD; Celine Mestel; Judith K. Gwathmey, VMD, PhD; Roger J. Hajjar, MD

From the Cardiovascular Research Center (F.H., D.L., C.M., R.J.H.), Massachusetts General Hospital and Harvard Medical School (J.K.G.), Boston, Mass, and INSERM U572 (C.C.), Hôpital Lariboisière, Paris, France.

Correspondence to Roger J. Hajjar, MD, Cardiovascular Research Center, Massachusetts General Hospital, 149 13th St, CNY-4, Charlestown, MA 02129. E-mail hajjar{at}cvrc.mgh.harvard.edu

Background— Aging is an independent risk factor for the development of cardiovascular disease. Clinical application of myocardial gene transfer may be best suited in the elderly. In vivo gene transfer by adenovirus is less efficient in aging myocardium.

Methods and Results— When infected with adenovirus containing ß-galactosidase (ß-gal) and green fluorescent protein (GFP) driven by cytomegalovirus promoters in vitro, aging rat cardiac myocytes exhibit significantly lower infectivity and delayed transgene expression compared with adult controls. Abnormalities of viral internalization may be one mechanism accounting for this difference. To investigate this, we studied expression levels of the coxsackievirus and adenovirus receptor (CAR) as well as other potential integrins involved in the internalization of adenoviruses. CAR expression tended to be upregulated whereas among potential integrins, {alpha}3ß1 was downregulated in aging cardiac myocytes. Blocking the ß1 component of {alpha}3ß1 further decreased infectivity, suggesting that the interaction between the penton base of the adenovirus and ß1 maybe a crucial component of the viral entry mechanism.

Conclusions— These results suggest that it is integrin-stimulated internalization rather than the adenovirus-CAR interaction that plays a vital role in adenoviral entry. The downregulation of integrins observed in senescent cells may be a key mechanism accounting for the decrease in viral infectivity seen in these cells. These findings have implications for the gene therapy treatment of myocardial failure in the elderly.


Key Words: aging • gene therapy • myocytes • viruses • receptors




This article has been cited by other articles:


Home page
Physiol. Rev.Home page
J. Davis, M. V. Westfall, D. Townsend, M. Blankinship, T. J. Herron, G. Guerrero-Serna, W. Wang, E. Devaney, and J. M. Metzger
Designing Heart Performance by Gene Transfer
Physiol Rev, October 1, 2008; 88(4): 1567 - 1651.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
A R Lyon, M Sato, R J Hajjar, R J Samulski, and S E Harding
Gene therapy: targeting the myocardium
Heart, January 1, 2008; 94(1): 89 - 99.
[Abstract] [Full Text] [PDF]


Home page
PhysiologyHome page
H. Ly, Y. Kawase, R. Yoneyama, and R. J. Hajjar
Gene Therapy in the Treatment of Heart Failure
Physiology, April 1, 2007; 22(2): 81 - 96.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
A. Pelletier, E. Joly, M. Prentki, and L. Coderre
Adenosine 5'-Monophosphate-Activated Protein Kinase and p38 Mitogen-Activated Protein Kinase Participate in the Stimulation of Glucose Uptake by Dinitrophenol in Adult Cardiomyocytes
Endocrinology, May 1, 2005; 146(5): 2285 - 2294.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
G. Suzuki, T.-C. Lee, J. A. Fallavollita, and J. M. Canty Jr
Adenoviral Gene Transfer of FGF-5 to Hibernating Myocardium Improves Function and Stimulates Myocytes to Hypertrophy and Reenter the Cell Cycle
Circ. Res., April 15, 2005; 96(7): 767 - 775.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
C. Emanueli, M. B. Salis, S. Van Linthout, M. Meloni, E. Desortes, J.-S. Silvestre, M. Clergue, C. D. Figueroa, S. Gadau, G. Condorelli, et al.
Akt/Protein Kinase B and Endothelial Nitric Oxide Synthase Mediate Muscular Neovascularization Induced by Tissue Kallikrein Gene Transfer
Circulation, September 21, 2004; 110(12): 1638 - 1644.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
F. Huq, D. Lebeche, V. Iyer, R. Liao, and R. J. Hajjar
Gene Transfer of Parvalbumin Improves Diastolic Dysfunction in Senescent Myocytes
Circulation, June 8, 2004; 109(22): 2780 - 2785.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
H. Ma, C. M. Sumbilla, I. K. G. Farrance, M. G. Klein, and G. Inesi
Cell-specific expression of SERCA, the exogenous Ca2+ transport ATPase, in cardiac myocytes
Am J Physiol Cell Physiol, March 1, 2004; 286(3): C556 - C564.
[Abstract] [Full Text]


Home page
CirculationHome page
S. Rajagopalan, E. R. Mohler III, R. J. Lederman, F. O. Mendelsohn, J. F. Saucedo, C. K. Goldman, J. Blebea, J. Macko, P. D. Kessler, H. S. Rasmussen, et al.
Regional Angiogenesis With Vascular Endothelial Growth Factor in Peripheral Arterial Disease: A Phase II Randomized, Double-Blind, Controlled Study of Adenoviral Delivery of Vascular Endothelial Growth Factor 121 in Patients With Disabling Intermittent Claudication
Circulation, October 21, 2003; 108(16): 1933 - 1938.
[Abstract] [Full Text] [PDF]